Saturday, 31 October 2026European Markets

ARCHER Stock Soars 21% As Investors Cheer Promising News

Loading stream...

(VIANEWS) - OSLO, Norway - Shares of ARCHER (GI: ARCH.OL) experienced an unexpected surge on Friday with a 21.06% jump to Kr1.08 at 14:48 EST after trading down in previous sessions. Furthermore, Oslo Bors Benchmark Index_GI has also experienced growth, rising by 0.25% to Kr1,277.66. ARCHER closed at kr0.89 last Friday, which is 82.82% lower than its 52-week high of kr5.17. While this recent rise may signal positive shift in its performance, investors must remember that past performance does not guarantee future outcomes and should remain vigilant to market trends and company news to make informed decisions.

About ARCHER

Archer Limited is a global oilfield service provider, offering products and services to the oil and gas industry since 2007. Operating through two segments in both hemispheres - Eastern and Western Hemispheres - Archer provides oiltools, digital well integrity solutions, drilling services, production engineering wireline services, equipment rental as well as global presence with offices located across North America, South America Europe as well as internationally with its headquarter located in Sandnes Norway since 2007. Archer was initially founded under its former name Seawell Limited before changing to Archer in 2011 (previously known as Seawell Limited).

Yearly Analysis

Here is a thorough evaluation of ARCHER's stock using available data: Yearly Top and Bottom Value: WARNER's stock (kr1.08) has seen substantial price fluctuations over the past year, trading well below its 52-week high of 5.17 and above its low of 0.76. This indicates significant price movements over that time period. Anticipated Sales Growth: ARCHER has projected 14.6% sales growth this year compared to similar companies within its industry, while for next year its expected sales growth is 6.4% - still positive but slower. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA): ARCHER has posted an EBITDA figure of 260.9 which indicates it is making profits prior to accounting for interest, taxes, depreciation and amortization costs. A healthy EBITDA may serve as an indicator of its financial health and stability. Overall, ARCHER stock appears to be trading at a lower price than its 52-week high but remains above its 52-week low. This year and next, sales growth is anticipated while EBITDA remains positive; investors should take all relevant information into consideration before making investment decisions.

Technical Analysis

ARCHER's stock has experienced a striking disparity between its current value and both of its 50-day and 200-day moving averages, as its stock value currently stands at kr4.65, higher than both averages. This indicates both short-term and long-term downward trends for this company's shares. Additionally, the stock's trading volume for the day reached 34,787,693, which was 514.744% higher than its daily average volume of 5,658,920. This spike may have been driven by investors responding to recent price movements or anticipating potential shifts in its trend. Regarding volatility, ARCHER has demonstrated a downward trend in its intraday variation averages for the last week, month, and quarter. Its highest amplitude of average volatility was 1.20% last week, 1.80% month before, and 2.00% quarter after quarter; suggesting its stock price has been relatively stable but has experienced recent fluctuations. Overall, ARCHER stock has experienced both short- and long-term declines with increased trading volume and volatility. Investors should closely follow its performance before making any definitive investment decisions.

Quarter Analysis

ARCHER has demonstrated strong sales growth for the coming quarter, posting an impressive 31% surge. Revenue Growth Year-on-year, the company has experienced impressive quarterly revenue growth of 25.4% resulting in 905M in revenues generated over twelve trailing months - signifying an upward trajectory in income over time.

Equity Analysis

Based on the financial information provided, here's an analysis of ARCHER: Earnings Per Share (EPS)ARCHER currently boasts a trailing 12-months EPS of kr0.69, representing earnings per share for the past year. Meanwhile, its Price to Earnings Ratio (PE Ratio) stands at 1.56, suggesting investors are paying kr1.56 for every krone of annual earnings generated. Finally, ROE stands at negative-14.89% which suggests it is not efficiently producing profits relative to shareholder equity. Based on this analysis, it appears that ARCHER's profitability is low as indicated by their negative Return of Earnings Ratio and PE ratio. Investors should take other factors such as company growth prospects, industry trends and overall market conditions into consideration before making investment decisions.

More news about ARCHER (ARCH.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com